Relay Therapeutics Files Q1 2025 10-Q
Ticker: RLAY · Form: 10-Q · Filed: May 5, 2025 · CIK: 1812364
| Field | Detail |
|---|---|
| Company | Relay Therapeutics, Inc. (RLAY) |
| Form Type | 10-Q |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Relay Tx Q1 2025 10-Q filed. Shows Treasury Securities & Money Market Funds.
AI Summary
Relay Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and operational highlights. Key financial instruments mentioned include U.S. Treasury Securities and Money Market Funds, with fair value measurements detailed.
Why It Matters
This filing provides investors with an update on Relay Therapeutics' financial health and investment portfolio as of the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2025-03-31 — Reporting Date (End of the reporting period for financial statements.)
- 2025-05-05 — Filing Date (Date the 10-Q was submitted to the SEC.)
Key Players & Entities
- Relay Therapeutics, Inc. (company) — Filer of the 10-Q
- 0000950170-25-063553 (other) — Accession Number for the filing
- 20250331 (date) — Reporting period end date
- 20250505 (date) — Filing date
- 399 BINNEY STREET (other) — Company's business and mail address
- CAMBRIDGE, MA (other) — Company's business and mail city and state
- 02139 (other) — Company's business and mail zip code
- 001-39385 (other) — SEC File Number
- DEShaw Research (company) — Mentioned in relation to a date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
The filing date (FILED AS OF DATE) is 20250505.
What are some of the financial instruments mentioned in the filing?
The filing mentions U.S. Treasury Securities, Money Market Funds, and US Government Agencies Debt Securities.
What is Relay Therapeutics, Inc.'s primary business classification?
The Standard Industrial Classification is BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836].
Where is Relay Therapeutics, Inc. located?
The company's business address is 399 BINNEY STREET, 2ND FLOOR, CAMBRIDGE, MA 02139.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 5, 2025 regarding Relay Therapeutics, Inc. (RLAY).